Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts (Q40642135)

22 September 2017

title

Autocrine growth factor regulation of lysyl oxidase expression in transformed fibroblasts (English)

1 reference

22 September 2017

3

0 references

author name string

Amitha H Palamakumbura

series ordinal

1

1 reference

22 September 2017

Pascal Sommer

series ordinal

2

1 reference

22 September 2017

language of work or name

English

0 references

publication date

4 June 2003

1 reference

Journal of Biological Chemistry

22 September 2017

published in

1 reference

22 September 2017

volume

278

1 reference

22 September 2017

issue

33

1 reference

22 September 2017

page(s)

30781-30787

1 reference

Properties and Function of Lysyl Oxidase

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Metalloproteinase Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Intra- and extracellular enzymes of collagen biosynthesis as biological and chemical targets in the control of fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Lysyl oxidase cDNA of myofibroblast from mouse fibrotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Lysyl oxidase and rrg messenger RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Deficient production of lysyl oxidase in cultures of malignantly transformed human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Expression of Gene rrg Is Associated with Reversion of NIH 3Tt3 Transformed by LTR-c-H- ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Isolation of genes specifically expressed in flat revertant cells derived from activated ras-transformed NIH 3T3 cells by treatment with azatyrosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Quantitative polymerase chain reaction of lysyl oxidase mRNA in malignantly transformed human cell lines demonstrates that their low lysyl oxidase activity is due to low quantities of its mRNA and low levels of transcription of the respective gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Partial restoration of pre-transformation levels of lysyl oxidase and transin mRNAs in phenotypic ras revertants

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Functional analysis of the promoter and first intron of the human lysyl oxidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Epigenetic inhibition of lysyl oxidase transcription after transformation by ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Pre- and post-translational regulation of lysyl oxidase by transforming growth factor-beta 1 in osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Cytokine regulation of gingival fibroblast lysyl oxidase, collagen, and elastin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin in adrenal cancer: modulation of steroid hormone production, cytotoxicity in vitro, and clinical antitumor effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin, a novel antitumor compound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Antitumour activity of suramin analogues in human tumour cell lines and primary cultures of tumour cells from patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin inhibits wound healing following filtering procedures for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Ribosomal DNA: Molecular Evolution and Phylogenetic Inference

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Neural retina of chick embryo in organ culture: effects of blockade of growth factors by suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Human melanoma progression in skin reconstructs : biological significance of bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Basic fibroblast growth factor binding and processing by human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: A trivial phenomenon or a novel secretion mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

The effect of suramin on bleomycin-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Fully processed lysyl oxidase catalyst translocates from the extracellular space into nuclei of aortic smooth-muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Localization and activity of lysyl oxidase within nuclei of fibrogenic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Down-regulation of lysyl oxidase-induced tumorigenic transformation in NRK-49F cells characterized by constitutive activation of ras proto-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Altered adhesion features and signal transduction in NRK-49F cells transformed by down-regulation of lysyl oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Cloning of rat aorta lysyl oxidase cDNA: complete codons and predicted amino acid sequence [Erratum to document cited in CA112(25):230629x]

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin disrupts insulin-like growth factor-II (IGF-II) mediated autocrine growth in human SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin treatment in hormone- and chemotherapy-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

The growth factor inhibitor suramin reduces apoptosis and cell aggregation in protein-free CHO cell batch cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

A sensitive fluorometric assay for the determination of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Regulation of lysyl oxidase by interferon-gamma in rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Suramin in non-small cell lung cancer and advanced breast cancer. Two parallel phase II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Combining suramin and a chimeric toxin directed to basic fibroblast growth factor receptors increases therapeutic efficacy against human melanoma in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Histone H1 is a substrate for lysyl oxidase and contains endogenous sodium borotritide-reducible residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

TRAMP (tyrosine rich acidic matrix protein), a protein that co-purifies with lysyl oxidase from porcine skin. Identification of TRAMP as the dermatan sulphate proteoglycan-associated 22K extracellular matrix protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M305238200

21 January 2018

Identifiers

DOI

10.1074/JBC.M305238200

1 reference

22 September 2017

1 reference